IL-1F10: A Potential Drug Target and Biomarker (G84639)

Target Name: IL1F10

NCBI ID: G84639

IL-1F10: A Potential Drug Target and Biomarker

Interleukin-38 (IL-1F10) is a cytokine that plays a crucial role in the regulation of immune responses and inflammation. The production and function of IL-1F10 have been implicated in a wide range of diseases, including autoimmune disorders, chronic obstructive pulmonary disease (COPD), and heart failure. As a result, targeting IL-1F10 has emerged as a promising strategy for the development of new therapeutic approaches.

IL-1F10 is a cytokine that is expressed in a variety of tissues and cells, including immune cells, epithelial cells, and tissues. It is a member of the IL-1 family of cytokines, which include IL-1, IL-2, and IL-12. The primary function of IL-1F10 is to regulate the production and response of immune cells, as well as modulate inflammation.

IL-1F10 has been shown to play a key role in the regulation of immune cell function and the production of antibodies. In addition, it has been implicated in the regulation of inflammation, including the production of pro-inflammatory cytokines. IL-1F10 has also been shown to be involved in the regulation of cell survival and the modulation of cell differentiation.

The production and function of IL-1F10 have been implicated in a wide range of diseases, including autoimmune disorders, chronic obstructive pulmonary disease (COPD), and heart failure. For example, studies have shown that IL-1F10 is involved in the development of autoimmune disorders, including rheumatoid arthritis (RA) and multiple sclerosis (MS). In addition, IL-1F10 has been shown to be involved in the regulation of COPD, including the production of pro-inflammatory cytokines and the modulation of lung function.

In addition to its role in disease, IL-1F10 has also been shown to have potential as a drug target. The production and function of IL-1F10 have been implicated in the regulation of a wide range of cellular processes, including cell survival, cell proliferation, and inflammation. As a result, targeting IL-1F10 has emerged as a promising strategy for the development of new therapeutic approaches.

One potential approach to targeting IL-1F10 is the use of small molecules that can inhibit its activity. These small molecules can be designed to specifically interact with IL-1F10 and prevent it from interacting with its receptors. By inhibiting IL-1F10 activity, small molecules can be used to treat a wide range of diseases, including autoimmune disorders, COPD, and heart failure.

Another potential approach to targeting IL-1F10 is the use of antibodies that can specifically recognize and target it. These antibodies can be used to treat a wide range of diseases, including autoimmune disorders, COPD, and heart failure. By using antibodies to target IL-1F10, researchers can prevent it from interacting with its receptors and effectively treat the associated diseases.

In conclusion, IL-1F10 is a potential drug target and biomarker that has the potential to revolutionize our understanding of a wide range of diseases. The production and function of IL-1F10 have been implicated in a wide range of diseases, including autoimmune disorders, COPD, and heart failure. As a result, targeting IL-1F10 with small molecules or antibodies has the potential to be a highly effective strategy for the development of new therapeutic approaches.

Protein Name: Interleukin 1 Family Member 10

Functions: Cytokine with immunomodulatory activity. Alone, does not induce cytokine production, but reduces IL22 and IL17A production by T-cells in response to heat-killed Candida albicans. Reduces IL36G-induced production of IL8 by peripheral blood mononuclear cells. Increases IL6 production by dendritic cells stimulated by bacterial lipopolysaccharides (LPS). Ligand for IL-36R/IL1RL2

More Common Targets